IDH1/2 Mutations in Cancer Stem Cells and Their Implications for Differentiation Therapy

Isocitrate dehydrogenase 1 and 2 (IDH1/2) are enzymes recurrently mutated in various types of cancer, including glioma, cholangiocarcinoma, chondrosarcoma, and acute myeloid leukemia. Mutant IDH1/2 induce a block in differentiation and thereby contribute to the stemness and oncogenesis of their cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Molenaar, Remco J., Wilmink, Johanna W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721574/
https://www.ncbi.nlm.nih.gov/pubmed/34967233
http://dx.doi.org/10.1369/00221554211062499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721574/
https://www.ncbi.nlm.nih.gov/pubmed/34967233
http://dx.doi.org/10.1369/00221554211062499

Ejemplares similares